Prognosis Association of Hypocalcemia on Moderate-severe TBI, COHORTE STUDY
1 other identifier
observational
20
1 country
1
Brief Summary
Will have bad prognosis the patients with low calcium (less of 24 hrs of te admission in hospital)after moderate - severe TBI that the patients that do not developed this condition?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 8, 2010
CompletedFirst Posted
Study publicly available on registry
November 9, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedNovember 9, 2010
November 1, 2010
1.9 years
November 8, 2010
November 8, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Establishment an association between the patients that developed Hypocalcemia less 24 hrs after moderate-severe TBI with patients that did not develop this condition
2 years
Secondary Outcomes (1)
Identify the more relevant prognosis factors
2 years
Study Arms (1)
Calcium after moderate-severe TBI
Patients with moderate -severe TBI with less as 24 hrs , admitted in emergency. We will measure seric calcium to compare the differences between both groups
Interventions
Eligibility Criteria
Patients bettween 16 and 65 years old with moderate -severe TBI with less as 24 hours , without administration of steroids or statins
You may qualify if:
- Man - woman between 16-65 years old with moderate -severe TBI less as 24 hrs,Count with tomographic study
You may not qualify if:
- Use of steroids, use of statins, Administration of Tromethamine, calcium antagonists, fibrates, niacin, cyclosporine, macrolides.
- Unclassifiable lesions in brainstem
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Juan Manuel Viñas Rios
San Luis Potosí City, San Luis Potosí, 78210, Mexico
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 8, 2010
First Posted
November 9, 2010
Study Start
October 1, 2010
Primary Completion
September 1, 2012
Study Completion
November 1, 2012
Last Updated
November 9, 2010
Record last verified: 2010-11